Moreover, in human AD, mouse, and in vitro tauopathy models expressing mutant MAPT, increased p-tau levels resulted in decreased SNHG8 expression, increased stress granule formation, and elevated cytotoxic granule-associated RNA binding protein TIA1 (Bhagat et al., 2023). This evidence concerns the gene MAPT and Alzheimer disease.